CEO SUMMARY: Our second installment in this series describes an emerging new class of in vitro diagnostics (IVD) companies. These companies have analyzers and tests designed specifically to be simple to run, generate results in minutes, use small sample sizes, and cost less than even high-volume routine tests run in core labs. These new IVD competitors […]
New Class of IVD Firms Wants to Serve POCT in Near-Patient Settings
Innovators in Near-Patient, Point-of-Care Testing Systems
- By Robert Michel
- > From the Volume XXVIII, No. 13 - September 27, 2021 Issue
- Tags: 7wireVentures, Advocate Aurora Health, Albertsons, Alphabet, Amazon, Atrium Health, BARDA, Baylor Scott and White Health, Biomedical Advanced Research and Development Authority, CBC, chemiluminescent assay, CLA, clia certified, clia waived, complete blood cell count, COVID-19, Cue Health, CVS, digital CBC test, ELISA, enzyme-linked immunosorbent assay, EU Mark, EUA, FDA, FDA Emergency Use Authorization (EUA), Food and Drug Administration, Gen Y, Genalyte, Glen Tullman, Health and Human Services, HHS, in vitro diagnostics, IVD, ivd/lab informatics, Kroger, LabCorp, logical observation identifiers names and codes, loinc, Maverick Diagnostic System, MDS, Millennials, multi-analyte, Multi-Antigen Serology Panel, National Basketball Association, NBA, near-patient setting, OLO CBC analyzer, physician office laboratory, POL, Publix, Quest Diagnostics, radio immunoassay, RIA, Rite Aid, SARS-CoV-2, Sight diagnostics, Sight Diagnostics 510(k) clearance, Sonic Healthcare, Target, thyroid-stimulating hormone, Truvian Sciences, TSH, Verily, Walgreens, Walmart
